ME/CFS and Long Covid Research: 5 – 11 December 2023
ME/CFS and Long Covid Research: 5 – 11 December 2023 Read More »
The weekly research round-up includes recent publications about ME/CFS and Long Covid.
News
Research: Low-Dose Naltrexone Ineffective for Fibromyalgia
Research: Low-Dose Naltrexone Ineffective for Fibromyalgia Read More »
Low dose naltrexone proves disappointing for fibromyalgia patients in recent trial.
ME/CFS and Long Covid Research: 27 November – 04 December 2023
ME/CFS and Long Covid Research: 27 November – 04 December 2023 Read More »
The weekly research round-up includes recent publications about ME/CFS and Long Covid.
The ME Association: Meeting with Ingeus and a request for benefit assessment case studies
Last month Ellie Jones, Welfare Rights Adviser to the ME Association, met with the Director of Health at Ingeus.
ME/CFS and Long Covid Research: 21 – 27 November 2023
ME/CFS and Long Covid Research: 21 – 27 November 2023 Read More »
The weekly research round-up includes recent publications about ME/CFS and Long Covid.
Medscape: New Tests May Finally Diagnose Long Covid
Medscape: New Tests May Finally Diagnose Long Covid Read More »
One of the biggest challenges facing clinicians who treat long
The Times: ‘Hospitals have no services for most severe ME cases, coroner told’
The Times: ‘Hospitals have no services for most severe ME cases, coroner told’ Read More »
Maeve Boothby-O’Neill, the daughter of the Times journalist Sean O’Neill, died 2 years ago after becoming bedbound.
ME Association Research Review: Mortality in ME/CFS
ME Association Research Review: Mortality in ME/CFS Read More »
Malnutrition is the most serious life-threatening complication in those with ME/CFS, especially in very severe cases.
BBC News: ‘Long Covid triggered our MCAS, but doctors didn’t believe us’.
BBC News: ‘Long Covid triggered our MCAS, but doctors didn’t believe us’. Read More »
“A growing number of people have secondary illnesses thought to be triggered by Long Covid – including an immune disorder called MCAS…”
ME/CFS and Long Covid Research: 16 – 20 November 2023
ME/CFS and Long Covid Research: 16 – 20 November 2023 Read More »
The weekly research round-up includes recent publications about ME/CFS and Long Covid.
Dr Shepherd responds to Parliamentary Q&A: Is there a connection between Long Covid and ME/CFS?
Dr Charles Shepherd responds to MP Jim Shannon about the similarities and overlap of ME/CFS and Long Covid
ME/CFS and Long Covid Research: 06 – 15 November 2023
ME/CFS and Long Covid Research: 06 – 15 November 2023 Read More »
The weekly research round-up includes recent publications about ME/CFS and Long Covid.
Raman research set to continue thanks to Ramsay Research funding from the ME Association
Raman research set to continue thanks to Ramsay Research funding from the ME Association Read More »
The ME Association (MEA) is pleased to announce that the
TIME Magazine: A new radical approach needed for Long COVID research
TIME Magazine: A new radical approach needed for Long COVID research Read More »
With no treatment or cure in sight for Long Covid patients, who is really to blame for 3 years of disappointing clinical research results?
Rapamycin Pilot Treatment Trial for ME/CFS
Rapamycin Pilot Treatment Trial for ME/CFS Read More »
Rapamycin therapy inhibits mTOR and reduces autophagy disruption. We believe
Research: Long Covid treatment trial: Donepezil hydrochloride
Research: Long Covid treatment trial: Donepezil hydrochloride Read More »
The effect of donepezil hydrochloride on post-COVID memory impairment: A
ME/CFS and Long Covid Research: 31 October – 6 November 2023
ME/CFS and Long Covid Research: 31 October – 6 November 2023 Read More »
The weekly research round-up includes recent publications about ME/CFS and Long Covid.
DHSC: Development of a Delivery Plan on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
The DHSC have published an update on the Interim Delivery Plan now consultations are closed and they are considering all responses received.
Hyperbaric oxygen therapy (HBOT) clinics should not be claiming that HBOT can be used to treat Long Covid
The Advertising Standards Agency (ASA) challenged whether the claims that
The ME Association raises concerns about new research promoting CBT as a treatment for ME/CFS
Medical Xpress has reported on the following published research ‘Cognitive